Revvity, Inc. (NYSE: RVTY), based in Waltham, Massachusetts, is advancing its software and informatics division, Revvity Signals, with the introduction of two innovative software solutions - Signals SynergyTM and Signals ClinicalTM. Requiring a shift from traditional communication and data analysis methods, these solutions seek to redefine the relationship between pharmaceutical and clinical trial industries and their contract partners.
Revvity Signals’ newly announced software, Signals SynergyTM, aims to overcome collaboration barriers and enhance project management between pharmaceutical and biotechnology sponsors and their external contract partners. The software offers improved data exchange functionality, providing an effective communication platform that extends beyond email and file-sharing platforms. This innovation is created with an understanding of the complexity and importance of accurately reporting scientific findings, laying the groundwork for a more productive and informed partnership dynamic.
In addition to Signals SynergyTM, Revvity has disclosed another pioneering software called Signals ClinicalTM. This software-as-a-service (SaaS) solution spearheads a new age in clinical data science. Featuring an end-to-end clinical data science platform, the tool is intended to aggregate all clinical trial data. This centralization of data taps into the prospect of delivering immediate, actionable insights that aid in swift clinical decisions. This, in turn, could hasten the market delivery of therapeutics, consequential in potentially saving lives.
Signals ClinicalTM becomes even more powerful when paired with Spotfire’s enterprise-class capabilities, facilitating seamless integration that further boosts its efficacy.
Following the introduction of these two innovative solutions, Revvity enhances its advancement in enhancing the synergy between pharmaceutical and contracting partners and streamlining data-driven decision-making within clinical trials. These cutting-edge solutions by Revvity Signals epitomize a new era where data exchange and collaboration are not just crucial but set the bar for industry standards.
Comments